Literature DB >> 8631990

Phosphorylation of cholecystokinin receptors expressed on Chinese hamster ovary cells. Similarities and differences relative to native pancreatic acinar cell receptors.

F Ozcelebi1, R V Rao, E Holicky, B J Madden, D J McCormick, L J Miller.   

Abstract

Phosphorylation of G protein-coupled receptors is an established mechanism for desensitization in response to agonist stimulation. We previously reported phosphorylation of the pancreatic acinar cell cholecystokinin (CCK) receptor and the establishment of two-dimensional phosphopeptide mapping of its sites of phosphorylation (Ozcelebi, F., and Miller, L. J. (1995) J. Biol. Chem. 270, 3435-3441). Here, we use similar techniques to map sites of phosphorylation of the same receptor expressed on a stable receptor-bearing Chinese hamster ovary (CHO)-CCKR cell line. Like the native cell, the CHO-CCKR cell receptor was phosphorylated in response to agonist stimulation in a concentration-dependent manner; however, the time course was quite different. CHO-CCKR cell receptor phosphorylation increased progressively to a plateau after 15 min, while in the acinar cell it peaks within 2 min and returns to baseline over this interval. There were distinct qualitative and quantitative differences in the sites of phosphorylation of the two receptor systems. One site previously attributed to action of a staurosporine-insensitive kinase in the acinar cell was absent in the CHO-CCKR cell. Site-directed mutagenesis was utilized to eliminate predicted sites of protein kinase C action, but only two of four such sites affected the phosphopeptide map of this receptor. Chemical and radiochemical sequencing were performed on these and other phosphopeptides which were present in both the CHO-CCKR cells and agonist-stimulated pancreatic acinar cells to provide direct evidence for the phosphorylation sites actually utilized. Thus, these data support the usefulness and limitations of a model cell system in studying receptor phosphorylation and desensitization.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631990     DOI: 10.1074/jbc.271.7.3750

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Novel roles for β-arrestins in the regulation of pharmacological sequestration to predict agonist-induced desensitization of dopamine D3 receptors.

Authors:  C Min; M Zheng; X Zhang; M G Caron; K M Kim
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

Review 2.  Regulatory mechanisms that modulate signalling by G-protein-coupled receptors.

Authors:  S K Böhm; E F Grady; N W Bunnett
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

3.  Contributing mechanisms underlying desensitization of cholecystokinin-induced activation of primary nodose ganglia neurons.

Authors:  Cody W Kowalski; Jonathan E M Lindberg; Daniel K Fowler; Steven M Simasko; James H Peters
Journal:  Am J Physiol Cell Physiol       Date:  2020-02-19       Impact factor: 4.249

4.  Ligand-induced internalization of the type 1 cholecystokinin receptor independent of recognized signaling activity.

Authors:  Erin E Cawston; Kaleeckal G Harikumar; Laurence J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-02       Impact factor: 4.249

5.  The cholecystokinin analogues JMV-180 and CCK-8 stimulate phospholipase C through the same binding site of CCK(A) receptor in rat pancreatic acini.

Authors:  E Sarri; B Ramos; G M Salido; E Claro
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

6.  Site specificity of agonist and second messenger-activated kinases for somatostatin receptor subtype 2A (Sst2A) phosphorylation.

Authors:  Qisheng Liu; Mark S Bee; Agnes Schonbrunn
Journal:  Mol Pharmacol       Date:  2009-04-23       Impact factor: 4.436

Review 7.  Structural basis of cholecystokinin receptor binding and regulation.

Authors:  Laurence J Miller; Fan Gao
Journal:  Pharmacol Ther       Date:  2008-05-11       Impact factor: 12.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.